InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.05
(
-0.21%
)
US TECH 100
19,659.60
(
-0.22%
)
Dow Jones
42,454.12
(
-0.14%
)
Brent Oil
78.47
(
-0.75%
)
Bitcoin
61,130.72
(
1.43%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

wrkingcapital

Send PM Follow Ignore
Followers 0
Posts 59
Boards Moderated 0
Alias Born 08/31/2010

wrkingcapital

Re: None

Tuesday, 09/07/2010 4:23:03 PM

Tuesday, September 07, 2010 4:23:03 PM

Post# of 80490
Just to chime in, I'm on 60 mg, and with very mild side effects. Of course, everyone reacts differently. One thing to remember when looking at response rates to AP24534, is that that is from a population that already failed a first and second line TKI, so it's not really apples to apples. I am like the others on the drug, very optimistic that it will take CML treatment to the next level, and get us closer and closer to a drug that puts everyone with CML in remission.

I was CCR and 2.8 log reduction at 3 month on Ariad, officially hit MMR by 6 month. I'm hovering around 0.03% (IS) right now.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up